100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2012 Research Grants

Abramson Family Cancer Research Institute at the University of Pennsylvania
Carl June, M.D., Gregory Beatty, Ph.D.
Immunotherapy Clinical Trial

Cambridge Research Institute UK
Douglas T. Fearon, Ph.D.
Dissection of Cancer-Induced Cachexia and Muscle Wasting

Cold Spring Harbor Laboratory
Memorial Sloan Kettering Cancer Center
Mikala Egeblad, Ph.D.
Scott Lowe, Ph.D.
Dynamics of Development and Maintenance of Tumor-Stroma Interactions in Pancreatic Cancer.

Columbia University Medical Center
Timothy C. Wang, M.D.
Role of Neurons in the Development and Progression of Pancreatic Cancer.

Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Institute
Scripps Research Institute
Alec Kimmelman, M.D., Ph.D.
Lewis Cantley, Ph.D.
Luke Lairson, Ph.D.
Development of Small Molecule Inhibitors of the Pancreatic Cancer Metabolism.

Fred Hutchinson Cancer Research Center
Sunil Hingorani, M.D., Ph.D.
Mechanisms Driving Interstitial Fluid Pressures in PDA

Harvard Medical School
Dana Farber Cancer Institute
The David H. Koch Institute for Integrative Cancer Research at MIT
William C. Hahn, M.D., Ph.D.
Sangeeta Bhatia, M.D., Ph.D.
Treatment of Pancreatic Cancer by Tumor-Penetrating Delivery of siRNA

Johns Hopkins University School of Medicine
Bert Vogelstein, M.D.
Detection of Early Pancreatic Neoplasia
Two Clinical Trials with 1,600 Patients Across Five Continents Aims at Developing Diagnostic Tests

Lustgarten Foundation Pancreatic Cancer Laboratory
David Tuveson, M.D., Ph.D. - Cold Spring Harbor Laboratory

Memorial Sloan Kettering Cancer Center
Peter Allen, M.D.
Detection of Early Pancreatic Neoplasia

Memorial Sloan Kettering Cancer Center in Collaboration with Dana-Farber Cancer Institute
Sha'are Zedek Medical Center and Rabin Medical Center, Israel
Eileen O'Reilly, M.D.
David Kelsen, M.D.
Testing Promising Drug Combinations in BRCA1 and BRCA2 Patients

New York-Presbyterian Hospital
Colombia University Medical Center
Ken Olive, Ph.D.
Focused Ultrasound Technologies for Diagnosis, Monitoring,and Treatment of Pancreatic Cancer

New York University of Medicine
Dafna Bar-Sagi, Ph.D.
Harnessing the Metabolic Vulberability of Pancreatic Cancer Cells to Develop Novel Therapies

New York University School of Medicine
George Miller, M.D.
Analysis of the Effects of the Intestional Microbiome in Pancreatic Cancer

The David H. Koch Institute for Integrative Cancer Research at MIT
Tyler Jacks, Ph.D.
Combination Therapies Targeting K-ras Pathways.

Stand Up To Cancer Dream Team Translational Cancer Research Grant
Daniel Von Hoff, M.D.,FACP - Translational Genomics Research Institute
Craig Thompson, M.D.,- Memorial Sloan Kettering Cancer Center

Thomas Jefferson University Kimmel Cancer Center
Teresa A. Zimmers, Ph.D.
Building a Map of Pancreatic Cancer Cachexia and Muscle Wasting

Translational Genomics Research Institute
Daniel Von Hoff, M.D.
Targeting Stromal Collagen in Pancreatic Cancer

University of California, San Diego
Roger Y. Tsien, Ph.D.
Magnetic Resonance Imaging of Pancreatic Cancer wth Contrast Agents Targeted by Activatable Cell-Penetrating Peptides (ACPPD)

University of Indiana
Max Schmidt, M.D., Ph.D.
Detection of Early Pancreatic Neoplasia

University of North Carolina School of Medicine
Jen Jen Yeh, M.D.
Defining the Pancreatic Cancer Kinome Landscape

University of Pittsburgh Cancer Institute
Stephen Thorne, Ph.D.
Novel Oncolytic Vaccine Strains for Targeted Pancreatic Cancer Therapy

Vanderbilt University
H. Charles Manning, Ph.D.
Novel TSPO PET Ligands to Image Pancreatic Cancer

Walter & Eliza Hall Institute, Australia
Peter Gibbs, M.D., M.B.B.S., FRACP
Defining of Early Pancreatic Neoplasia

Weizmann Institute of Science
Hadassa Degani, Ph.D.
Development of Multi-Parametric Magnetic Resonance Imaging Approach for Early Pancreatic Cancer Diagnosis.

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303